The 340B Drug Pricing Program was designed to help poor patients access healthcare services. Yet, despite this program growing to $66 billion, primarily benefiting hospitals, medical debt continues to be a crippling financial burden for many Americans, with most of the debt being owed to these 340B-eligible hospitals. This system is failing them! Patients are starting to ask the question: Is the 340B Program the Next ‘Too Big to Fail’?